We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Acushnet Holdings
GOLF
$6B
| $1.12M | ﹤0.01% |
+25,825
| New | +$1.24M |
|
2327
Voyager Therapeutics
VYGR
$181M
| $1.12M | ﹤0.01% |
+189,736
| New | +$1.21M |
|
2328
Ingredion
INGR
$6.42B
| $1.12M | ﹤0.01% |
13,936
+4,365
| +46% | +$383K |
|
2329
Carvana
CVNA
$47.4B
| $1.12M | ﹤0.01% |
275,995
-12,418,590
| -98% | -$81M |
|
2330
MDU Resources
MDU
$4.18B
| $1.12M | ﹤0.01% |
+107,528
| New | +$1.19M |
|
2331
TriplePoint Venture Growth BDC
TPVG
$183M
| $1.12M | ﹤0.01% |
102,979
+71,022
| +222% | +$925K |
|
|
RVNC
2332
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.11M | ﹤0.01% |
41,253
+24,395
| +145% | +$495K |
|
|
FOUNW
2333
CALL
DELISTED
Founder SPAC Warrants
FOUNW
| $1.11M | ﹤0.01% |
523,000
-87,055
| -14% | -$25.9K |
|
|
THRD
2334
DELISTED
Third Harmonic Bio
THRD
| $1.11M | ﹤0.01% |
+58,465
| New | +$1.05M |
|
|
SJI
2335
DELISTED
South Jersey Industries, Inc.
SJI
| $1.11M | ﹤0.01% |
+33,214
| New | +$1.13M |
|
2336
PUT
Alphabet (Google) Class C
GOOG
$4.1T
| $1.11M | ﹤0.01% |
11,500
-542,500
| -98% | -$60.6M |
|
|
EXAS
2337
DELISTED
Exact Sciences
EXAS
| $1.1M | ﹤0.01% |
33,823
+27,621
| +445% | +$1.14M |
|
2338
Beyond Meat
BYND
$275M
| $1.09M | ﹤0.01% |
+77,258
| New | +$2.13M |
|
2339
Brinker International
EAT
$8.82B
| $1.08M | ﹤0.01% |
43,432
+28,150
| +184% | +$760K |
|
2340
CALL
Arista Networks
ANET
$199B
| $1.08M | ﹤0.01% |
+38,400
| New | +$1.11M |
|
2341
Helen of Troy
HELE
$654M
| $1.08M | ﹤0.01% |
11,200
-11,303
| -50% | -$1.45M |
|
2342
Grupo Aeroportuario del Pacifico
PAC
$12.9B
| $1.08M | ﹤0.01% |
8,524
+51
| +0.6% | +$7.23K |
|
|
EBACW
2343
CALL
DELISTED
European Biotech Acquisition Corp. Warrant
EBACW
| $1.08M | ﹤0.01% |
108,584
| – | – |
|
2344
Smith & Nephew
SNN
$13.7B
| $1.07M | ﹤0.01% |
46,286
-58,042
| -56% | -$1.49M |
|
|
DHAI
2345
DELISTED
DIH Holdings US
DHAI
| $1.07M | ﹤0.01% |
4,280
| – | – |
|
2346
Aldeyra Therapeutics
ALDX
$96.5M
| $1.07M | ﹤0.01% |
200,163
+122,482
| +158% | +$735K |
|
|
GHL
2347
DELISTED
Greenhill & Co., Inc.
GHL
| $1.07M | ﹤0.01% |
179,939
+149,656
| +494% | +$1.18M |
|
|
ABVEW
2348
CALL
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
| $1.07M | ﹤0.01% |
107,213
| – | – |
|
2349
Regency Centers
REG
$14.8B
| $1.06M | ﹤0.01% |
+19,700
| New | +$1.2M |
|
2350
MGP Ingredients
MGPI
$403M
| $1.06M | ﹤0.01% |
9,977
+7,202
| +260% | +$774K |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.